VIR

9.06

0.00% 0.00

Handel nachbörslich: 9.00 -0.06 -0.66%

Vir Biotechnology Inc (VIR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt VIR? Forum Prognose

Schlusskurs vom Vortag:

$9.06

Offen:

$8.92

24-Stunden-Volumen:

1.36M

Relative Volume:

0.42

Marktkapitalisierung:

$1.45B

Einnahmen:

$68.56M

Nettoeinkommen (Verlust:

$-437.99M

KGV:

-2.8636

EPS:

-3.1639

Netto-Cashflow:

$-396.61M

1W Leistung:

+7.09%

1M Leistung:

-5.13%

6M Leistung:

+62.08%

1J Leistung:

+62.37%

1-Tages-Spanne:

$8.92

$9.27

1-Wochen-Bereich:

$8.64

$9.40

52-Wochen-Spanne:

$4.155

$10.94

Vir Biotechnology Inc Stock (VIR) Company Profile

Firmenname

Vir Biotechnology Inc

Sektor

Healthcare (1116)

Branche

Biotechnology (624)

Telefon

415-906-4324

Adresse

1800 OWENS STREET, SAN FRANCISCO, CA

Mitarbeiter

367

Twitter

@Vir_Biotech

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

VIR's Discussions on Twitter

Compare VIR vs VRTX, REGN, ARGX, ALNY, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VIR Vir Biotechnology Inc	9.06	1.45B	68.56M	-437.99M	-396.61M	-3.1639
VRTX Vertex Pharmaceuticals Inc	434.30	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	763.04	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	748.25	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	330.34	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	163.81	35.01B	606.42M	-1.28B	-997.58M	-6.403

Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-24	Hochstufung	Raymond James	Outperform → Strong Buy
2025-09-03	Eingeleitet	Evercore ISI	Outperform
2025-08-27	Hochstufung	BofA Securities	Neutral → Buy
2024-01-29	Herabstufung	JP Morgan	Overweight → Neutral
2023-09-08	Herabstufung	BofA Securities	Buy → Neutral
2023-03-06	Hochstufung	JP Morgan	Neutral → Overweight
2023-02-21	Hochstufung	Goldman	Neutral → Buy
2023-01-27	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2022-09-14	Eingeleitet	SVB Leerink	Outperform
2022-09-09	Eingeleitet	Morgan Stanley	Underweight
2022-03-03	Hochstufung	Robert W. Baird	Underperform → Neutral
2021-12-21	Herabstufung	Robert W. Baird	Neutral → Underperform
2021-10-25	Hochstufung	JP Morgan	Underweight → Neutral
2021-09-22	Herabstufung	Goldman	Buy → Neutral
2021-06-04	Fortgesetzt	Robert W. Baird	Neutral
2021-01-27	Herabstufung	JP Morgan	Neutral → Underweight
2021-01-20	Bestätigt	H.C. Wainwright	Buy
2020-10-05	Eingeleitet	BofA Securities	Buy
2020-09-14	Hochstufung	Goldman	Neutral → Buy
2020-09-11	Hochstufung	JP Morgan	Underweight → Neutral
2020-08-20	Eingeleitet	Needham	Buy
2020-03-19	Herabstufung	JP Morgan	Neutral → Underweight
2020-03-13	Herabstufung	Goldman	Buy → Neutral
2020-02-27	Herabstufung	Robert W. Baird	Neutral → Underperform
2020-02-04	Herabstufung	JP Morgan	Overweight → Neutral
2019-11-14	Eingeleitet	Robert W. Baird	Neutral
2019-11-05	Eingeleitet	Barclays	Overweight
2019-11-05	Eingeleitet	Cowen	Outperform
2019-11-05	Eingeleitet	Goldman	Buy
2019-11-05	Eingeleitet	JP Morgan	Overweight

Alle ansehen

Vir Biotechnology Inc Aktie (VIR) Neueste Nachrichten

03:23 AM

VIR (NASDAQ: VIR) Form 144 shows 72,559-share sale after vesting - stocktitan.net

03:23 AM

10:27 AM

Evercore ISI Group Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation - MSN

10:27 AM

Apr 04, 2026

VIR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Apr 03, 2026

VIR SEC FilingsVir Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net

Apr 03, 2026

Apr 02, 2026

Market Catalysts: Is Vir Biotechnology Inc a good stock for dollar cost averaging2026 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn

Apr 02, 2026

Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus

Apr 02, 2026

Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock - marketbeat.com

Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares By Investing.com - za.investing.com

Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares - Investing.com

Apr 02, 2026

Vir Biotechnology (VIR) director sells 22,000 shares in open market - stocktitan.net

Apr 02, 2026

VIR Earnings History & Surprises | EPS & Revenue Results | VIR BIOTECHNOLOGY INC (NASDAQ:VIR) - ChartMill

Apr 02, 2026

Apr 01, 2026

Vir Biotechnology (VIR) price target increased by 26.10% to 20.74 - MSN

Apr 01, 2026

Mar 30, 2026

Energy Moves: Is Vir Biotechnology Inc stock a smart retirement pickPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Mar 30, 2026

Bull Bear: Is Vir Biotechnology Inc stock heavily shortedNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn

Mar 30, 2026

Investor Mood: How volatile is LGLWS stockWeekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Why did Vir Biotechnology stock surge 60% after-hours today? - MSN

Mar 29, 2026

Mar 28, 2026